To include your compound in the COVID-19 Resource Center, submit it here.

T-20 early access starting

Trimeris (TRMS) and partner Roche (SWX:ROCZ) said they will begin on Aug.

Read the full 125 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE